⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Tesamorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) consisting of 44 amino acids with a specialized hexenoyl group attached to the N-terminal. This structural modification enhances its resistance to enzymatic degradation, allowing for sustained somatotroph stimulation. In research settings, Tesamorelin is primarily investigated for its unique ability to reduce visceral adipose tissue (VAT) through the growth hormone-mediated lipolytic pathway. Beyond metabolism, it is also a subject of study in neurobiology for its potential role in improving cognitive performance and managing neurodegenerative markers. This high-purity lyophilized reagent provides a stable framework for exploring the endocrine axis and metabolic homeostasis in experimental models.
Product Specifications
Research Studies
Frequently Asked Questions
Related Products